# Wegovy **Source:** https://www.startuphub.ai/startups/wegovy **Profile type:** Startup > Wegovy is a prescription medication containing semaglutide used for chronic weight management in adults. ## About Wegovy is a GLP-1 receptor agonist medication developed by Novo Nordisk for the treatment of obesity and overweight conditions. It functions by mimicking hormones that target areas of the brain that regulate appetite and food intake. ## Key facts - **Slug:** wegovy - **Website:** https://www.wegovy.com - **Location:** Bagsværd, Denmark - **Operating status:** Active - **Sectors / tags:** Biotech, HealthTech, MedTech, Drug Discovery - **Social:** - Facebook: https://www.facebook.com/mywegovy ## Frequently asked ### What does Wegovy do? Wegovy is a GLP-1 receptor agonist medication developed by Novo Nordisk for the treatment of obesity and overweight conditions. It functions by mimicking hormones that target areas of the brain that regulate appetite and food intake. ### Where is Wegovy headquartered? Wegovy is headquartered in Bagsværd, Denmark. ### What industry does Wegovy operate in? Wegovy operates in Biotech, HealthTech, MedTech, Drug Discovery. ## JSON-LD Structured data aligned with this page's `